← Evidence map

ArticleGastroenterology & hepatology2026

When Should Pediatric Inflammatory Bowel Disease Patients Be Allowed to Take Approved Therapies for Adults?

Michael D KappelmanPubMed ↗Full text ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42388693